These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28329236)

  • 1. Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub-Saharan Africa.
    Phillips AN; Stover J; Cambiano V; Nakagawa F; Jordan MR; Pillay D; Doherty M; Revill P; Bertagnolio S
    J Infect Dis; 2017 May; 215(9):1362-1365. PubMed ID: 28329236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between HIV pretreatment drug resistance and virological outcomes in children and adults in sub-Saharan Africa: A systematic review and meta-analysis.
    Takem EN; Coox C; Shang J; Ndongmo C; Dokubo EK
    PLoS One; 2024; 19(4):e0300456. PubMed ID: 38626183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inequality in outcomes for adolescents living with perinatally acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis.
    CIPHER Global Cohort Collaboration
    J Int AIDS Soc; 2018 Feb; 21 Suppl 1(Suppl Suppl 1):. PubMed ID: 29485724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa.
    Hontelez JA; de Vlas SJ; Baltussen R; Newell ML; Bakker R; Tanser F; Lurie M; Bärnighausen T
    AIDS; 2012 Jul; 26 Suppl 1(0 1):S19-30. PubMed ID: 22781175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.
    Wallis CL; Godfrey C; Fitzgibbon JE; Mellors JW
    J Infect Dis; 2017 Dec; 216(suppl_9):S851-S856. PubMed ID: 29207000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints.
    Mikkelsen E; Hontelez JA; Jansen MP; Bärnighausen T; Hauck K; Johansson KA; Meyer-Rath G; Over M; de Vlas SJ; van der Wilt GJ; Tromp N; Bijlmakers L; Baltussen RM
    PLoS Med; 2017 Feb; 14(2):e1002240. PubMed ID: 28222126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial resistance in sub-Saharan Africa: an underestimated emergency.
    Kariuki S; Dougan G
    Ann N Y Acad Sci; 2014 Sep; 1323(1):43-55. PubMed ID: 24628272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients.
    Hofstra LM; Sánchez Rivas E; Nijhuis M; Bank LEA; Wilkinson E; Kelly K; Mudrikova T; Schuurman R; de Oliveira T; de Kort J; Wensing AMJ
    Clin Infect Dis; 2017 Apr; 64(8):1092-1097. PubMed ID: 28329390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.
    Collier D; Iwuji C; Derache A; de Oliveira T; Okesola N; Calmy A; Dabis F; Pillay D; Gupta RK;
    Clin Infect Dis; 2017 Apr; 64(8):1006-1016. PubMed ID: 28329393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attrition From Human Immunodeficiency Virus Treatment Programs in Africa: A Longitudinal Ecological Analysis Using Data From 307 144 Patients Initiating Antiretroviral Therapy Between 2005 and 2010.
    Elul B; Saito S; Chung H; Hoos D; El-Sadr W
    Clin Infect Dis; 2017 May; 64(10):1309-1316. PubMed ID: 28329244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.
    Natureeba P; Kakuru A; Muhindo M; Ochieng T; Ategeka J; Koss CA; Plenty A; Charlebois ED; Clark TD; Nzarubara B; Nakalembe M; Cohan D; Rizzuto G; Muehlenbachs A; Ruel T; Jagannathan P; Havlir DV; Kamya MR; Dorsey G
    J Infect Dis; 2017 Jul; 216(1):29-35. PubMed ID: 28329368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy.
    Lee S; Byakwaga H; Boum Y; Burdo TH; Williams KC; Lederman MM; Huang Y; Tracy RP; Cao H; Haberer JE; Kembabazi A; Bangsberg DR; Martin JN; Hunt PW
    J Infect Dis; 2017 Apr; 215(8):1270-1274. PubMed ID: 28329310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.
    Vibholm L; Schleimann MH; Højen JF; Benfield T; Offersen R; Rasmussen K; Olesen R; Dige A; Agnholt J; Grau J; Buzon M; Wittig B; Lichterfeld M; Petersen AM; Deng X; Abdel-Mohsen M; Pillai SK; Rutsaert S; Trypsteen W; De Spiegelaere W; Vandekerchove L; Østergaard L; Rasmussen TA; Denton PW; Tolstrup M; Søgaard OS
    Clin Infect Dis; 2017 Jun; 64(12):1686-1695. PubMed ID: 28329286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study.
    Parker RA; Rabideau DJ; Sax PE; Tierney C; Daar ES; Collier AC; Losina E; Freedberg KA
    Clin Infect Dis; 2017 Jun; 64(11):1612-1614. PubMed ID: 28329243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection.
    Lake JE; Stanley TL; Apovian CM; Bhasin S; Brown TT; Capeau J; Currier JS; Dube MP; Falutz J; Grinspoon SK; Guaraldi G; Martinez E; McComsey GA; Sattler FR; Erlandson KM
    Clin Infect Dis; 2017 May; 64(10):1422-1429. PubMed ID: 28329372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis.
    Proaño A; Bravard MA; López JW; Lee GO; Bui D; Datta S; Comina G; Zimic M; Coronel J; Caviedes L; Cabrera JL; Salas A; Ticona E; Vu NM; Kirwan DE; Loader MI; Friedland JS; Moore DAJ; Evans CA; Tracey BH; Gilman RH;
    Clin Infect Dis; 2017 May; 64(9):1174-1181. PubMed ID: 28329268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya.
    Inzaule SC; Hamers RL; Mukui I; Were K; Owiti P; Kwaro D; Rinke de Wit TF; Zeh C
    AIDS; 2017 Jun; 31(10):1495-1498. PubMed ID: 28398959
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.